Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Efficacy of cyclobutrifluram in controlling Fusarium crown rot of wheat and resistance risk of three Fusarium species to cyclobutrifluram

Pestic Biochem Physiol. 2023-12; 
Haiyan Sun, Shiyan Cai, Yuanyu Deng, Shulin Cao, Xiaoyue Yang, Yanteng Lu, Wei Li, Huaigu Chen
Products/Services Used Details Operation
Molecular Biology Reagents … The purified PCR products were sequenced by Genscript Co., Ltd. (Nanjing, China). The sequences were assembled and further aligned with Vector NTI and BioEdit software. To … Get A Quote

摘要

Cyclobutrifluram (TYMIRIUM® technology), a new succinate dehydrogenase inhibitor (SDHI) fungicide, is currently being registered by SYNGENTA for controlling Fusarium crown rot (FCR) of wheat in China. The application of 15 or 30 g of active ingredient/100 kg seed of cyclobutrifluram significantly reduced pre-emergence damping-off, discoloration on the stem base and formation of whiteheads caused by FCR. The EC values of cyclobutrifluram for 60 isolates of F. pseudograminearum, 30 isolates of F. asiaticum and 30 isolates of F. graminearum ranged from 0.016 to 0.142 mg L, 0.010 to 0.041 mg L and 0.012 to 0.059 mg L, respectively. One hundred and seven cyclobutrifluram-resistant (CR) mutants were obtained... More

关键词

Control efficacy, Cross-resistance, Cyclobutrifluram, Fusarium crown rot, Resistance risk, TYMIRIUM® technology
XML 地图